Impact of Intracoronary Versus Intravenous Epinephrine Administration During Cardiac Arrest .

CompletedOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2022

Conditions
Cardiopulmonary ArrestEpinephrine Causing Adverse Effects in Therapeutic Use
Interventions
DRUG

Epinephrin

The study will enroll acute myocardial infarction patients who suffered from a cardiac arrest in the cardiac catheterization laboratory during percutaneous intervention procedure. Cardiac Resuscitation was performed according to the European Resuscitation Council (ERC) Guidelines. The preferred route of epinephrine administration was through the central venous access (by internal jugular or subclavian vein). Thus, if available, it was the preferred method of medication delivery. However, in cases without central venous access, the route of epinephrine administration (peripheral intravenous or arterial intracoronary) during cardiac arrest was left to the treating physicians.

Trial Locations (1)

LT-50161

Ali Aldujeli, Kaunas

All Listed Sponsors
collaborator

Baylor Scott and White Health

OTHER

collaborator

Minneapolis Heart Institute

OTHER

lead

Lithuanian University of Health Sciences

OTHER

NCT05253937 - Impact of Intracoronary Versus Intravenous Epinephrine Administration During Cardiac Arrest . | Biotech Hunter | Biotech Hunter